New

Aktocyte Tablets

  • It will enhance the quality of life of cancer patients undergoing radiotherapy.
  • It is developed by Department of Atomic Energy and IDRS Labs Pvt. Ltd. Made by scientists.
  • It has received approval from FSSAI.
  • Its remarkable results have been seen in the treatment of pelvic cancer patients.
  • After this the need for surgical removal of the bladder was eliminated.
  • It is expected to hit the market in January 2024.

Related Articles

'Moidams' included in UNESCO World Heritage List
Model Skill Loan Scheme
Henley & Partners Passport Ranking
H 125 Helicopter
65th International Maths Olympiad Competition
Gross Environmental Product (GEP) Index
« »
  • SUN
  • MON
  • TUE
  • WED
  • THU
  • FRI
  • SAT
Have any Query?

Our support team will be happy to assist you!

+91-9555 124 124
info@sanskritiias.com
OR